Ashland will introduce Aroset™ Gentle 700, a new medical pressure
sensitive adhesive (PSA), at MD&M West in Anaheim, CA on February 5-7, 2019.
Aroset™ Gentle 700 PSA has been developed for medical use, to be skin friendly with good breathability
and to allow for minimal pain and trauma upon removal.
Key Aroset™ Gentle 700 PSA attributes & benefits include:
• user friendly (especially for sensitive skin)
• repositionable
• passed ISO 10993 biomedical compatibility testing
non-sensitizing
non-irritating
no cytotoxicity
• fast wet-out to skin (rapid bonding to skin)
• broad applications that include wound care and medical devices
“We are excited to introduce this product for the wound-care market, as well as the medical device
industry,” said Todd McMillen, global industry manager, PSA, Ashland. “Aroset™ Gentle 700 PSA
provides a better end-user experience as it allows for minimal trauma upon removal, especially for more
sensitive skin individuals.”
“In addition to its ability to release easily from the skin, Aroset™ Gentle 700 PSA can also be
repositioned or reapplied on dry skin,” added Lars Kilian, PhD, senior group leader, PSA product and
applications development, Ashland. “These attributes make this adhesive an excellent choice for selfadhesive
bandages and tapes, as well as other ‘peel-and-stick’ devices intended for low-impact skin
bonding applications.”